Skip to Content

Pfizer PBC 75 (Ibrance 75 mg)

Generic Name: palbociclib

Pill with imprint Pfizer PBC 75 is Orange, Capsule-shape and has been identified as Ibrance 75 mg. It is supplied by Pfizer Inc..

Ibrance is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug class CDK 4/6 inhibitors. Ibrance 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer PBC 75

Ibrance 75 mg Pfizer PBC 75

Ibrance

Generic Name:
palbociclib
Imprint:
Pfizer PBC 75
Strength:
75 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CDK 4/6 inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pfizer Inc.
National Drug Code (NDC):
00069-0187

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide